Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis Care & Research|December 1, 2011
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)Megan E B Clowse, Susannah C Copland, Tsung-Cheng Hsieh, et al.
Arthritis and Rheumatism|March 8, 2005
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosisJohn H Stone, Vinodh N Rajapakse, Gary S Hoffman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
Arthritis and Rheumatism|April 29, 2006
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept TrialJohn H Stone, Janet T Holbrook, Matthew A Marriott, et al.
Arthritis Care & Research|April 1, 2011
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisRavi Suppiah, Andrew Judge, Rajbir Batra, et al.
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Arthritis Care & Research|September 29, 2011
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)Gunnar Tomasson, Maarten Boers, Michael Walsh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 12, 2011
Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitorLichuan Liu, Jason S Halladay, Young Shin, et al.
Pageof 8